| Analysis | Metabolite Name | Measured Value | Units | stress | treatment |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 7836 | Peak area | Y | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 9004 | Peak area | Y | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 9318 | Peak area | Y | +Lacto |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 9917 | Peak area | Y | +Lacto |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 10696 | Peak area | N | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 11124 | Peak area | Y | +Lacto |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 12324 | Peak area | N | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 12937 | Peak area | Y | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 13386 | Peak area | N | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 13429 | Peak area | Y | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 15366 | Peak area | Y | +Lacto |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 15457 | Peak area | N | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 18006 | Peak area | Y | +Lacto |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 18284 | Peak area | Y | None |
| Reversed phase POSITIVE ION MODE | 3-METHYLHISTAMINE (CAS# 644-42-8); (M+H)+ | 22694 | Peak area | N | None |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|